Loading...

We've got a brand new version of Simply Wall St! Try it out

Ignite International Brands

CNSX:BILZ
Snowflake Description

Excellent balance sheet and slightly overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
BILZ
CNSX
CA$385M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Ignite International Brands, Ltd. operates in cannabis industry in the United States and Canada. The last earnings update was 22 days ago. More info.


Add to Portfolio Compare Print
  • Ignite International Brands has significant price volatility in the past 3 months.
BILZ Share Price and Events
7 Day Returns
21%
CNSX:BILZ
-0.2%
CA Pharmaceuticals
1.2%
CA Market
1 Year Returns
-
CNSX:BILZ
-45.8%
CA Pharmaceuticals
-0.4%
CA Market
BILZ Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Ignite International Brands (BILZ) 21% -25% 114.3% - - -
CA Pharmaceuticals -0.2% -1.8% -21.5% -45.8% 251% 334.4%
CA Market 1.2% 3.3% 0.8% -0.4% 7.4% 4.5%
1 Year Return vs Industry and Market
  • No trading data on BILZ.
  • No trading data on BILZ.
Price Volatility
Industry
5yr Volatility vs Market

BILZ Value

 Is Ignite International Brands undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Ignite International Brands to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Ignite International Brands.

CNSX:BILZ Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 6.8%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for CNSX:BILZ
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.7
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.704 (1 + (1- 26.5%) (2.55%))
0.81
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.81
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (0.81 * 5.96%)
6.78%

Discounted Cash Flow Calculation for CNSX:BILZ using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Ignite International Brands is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

CNSX:BILZ DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CAD, Millions) Source Present Value
Discounted (@ 6.78%)
2020 37.94 Est @ 41.59% 35.53
2021 49.20 Est @ 29.7% 43.16
2022 59.72 Est @ 21.37% 49.06
2023 69.00 Est @ 15.54% 53.08
2024 76.92 Est @ 11.47% 55.42
2025 83.54 Est @ 8.61% 56.37
2026 89.06 Est @ 6.61% 56.28
2027 93.70 Est @ 5.21% 55.45
2028 97.67 Est @ 4.23% 54.13
2029 101.13 Est @ 3.55% 52.49
Present value of next 10 years cash flows CA$510.00
CNSX:BILZ DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= CA$101.13 × (1 + 1.95%) ÷ (6.78% – 1.95%)
CA$2,134.66
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CA$2,134.66 ÷ (1 + 6.78%)10
CA$1,108.04
CNSX:BILZ Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CA$510.00 + CA$1,108.04
CA$1,618.04
Equity Value per Share
(CAD)
= Total value / Shares Outstanding
= CA$1,618.04 / 256.85
CA$6.3
CNSX:BILZ Discount to Share Price
Calculation Result
Value per share (CAD) From above. CA$6.30
Current discount Discount to share price of CA$1.50
= -1 x (CA$1.50 - CA$6.30) / CA$6.30
76.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Ignite International Brands is available for.
Intrinsic value
>50%
Share price is CA$1.5 vs Future cash flow value of CA$6.3
Current Discount Checks
For Ignite International Brands to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Ignite International Brands's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Ignite International Brands's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Ignite International Brands's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Ignite International Brands's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:BILZ PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in CAD CA$-0.40
CNSX:BILZ Share Price ** CNSX (2019-09-19) in CAD CA$1.5
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 18.72x
Canada Market PE Ratio Median Figure of 540 Publicly-Listed Companies 14.11x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Ignite International Brands.

CNSX:BILZ PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:BILZ Share Price ÷ EPS (both in CAD)

= 1.5 ÷ -0.40

-3.79x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ignite International Brands is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Ignite International Brands is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Ignite International Brands's expected growth come at a high price?
Raw Data
CNSX:BILZ PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.79x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.57x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Ignite International Brands, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Ignite International Brands's assets?
Raw Data
CNSX:BILZ PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in CAD CA$0.19
CNSX:BILZ Share Price * CNSX (2019-09-19) in CAD CA$1.5
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.32x
Canada Market PB Ratio Median Figure of 2,454 Publicly-Listed Companies 1.44x
CNSX:BILZ PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:BILZ Share Price ÷ Book Value per Share (both in CAD)

= 1.5 ÷ 0.19

8.07x

* Primary Listing of Ignite International Brands.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ignite International Brands is overvalued based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Ignite International Brands's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Ignite International Brands has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

BILZ Future Performance

 How is Ignite International Brands expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ignite International Brands has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
110.6%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Ignite International Brands expected to grow at an attractive rate?
  • Unable to compare Ignite International Brands's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Ignite International Brands's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Ignite International Brands's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:BILZ Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 110.6%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 58.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:BILZ Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:BILZ Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-06-30 6 27 -37
2019-03-31 4 -27
2018-12-31 3 -22 -17

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Ignite International Brands is high growth as no earnings estimate data is available.
  • Unable to determine if Ignite International Brands is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:BILZ Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Ignite International Brands Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:BILZ Past Financials Data
Date (Data in CAD Millions) EPS *
2019-06-30 -0.40
2019-03-31 -0.26
2018-12-31 -0.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Ignite International Brands will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Ignite International Brands's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Ignite International Brands's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Ignite International Brands's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Ignite International Brands's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Ignite International Brands has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

BILZ Past Performance

  How has Ignite International Brands performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Ignite International Brands's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Ignite International Brands does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Ignite International Brands's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Ignite International Brands's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Ignite International Brands's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Ignite International Brands Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:BILZ Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 6.07 -36.57 34.81
2019-03-31 4.05 -27.02 28.20
2018-12-31 2.58 -17.15 17.96

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Ignite International Brands has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Ignite International Brands has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Ignite International Brands improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Ignite International Brands's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Ignite International Brands has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

BILZ Health

 How is Ignite International Brands's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Ignite International Brands's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Ignite International Brands is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Ignite International Brands's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Ignite International Brands's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Ignite International Brands Company Filings, last reported 2 months ago.

CNSX:BILZ Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 48.54 3.96 22.33
2019-03-31 1.46 25.58 21.73
2018-12-31 13.07 5.30 13.28
  • Ignite International Brands's level of debt (8.2%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Ignite International Brands's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Ignite International Brands has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Ignite International Brands has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -403.6% per year.
X
Financial health checks
We assess Ignite International Brands's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Ignite International Brands has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

BILZ Dividends

 What is Ignite International Brands's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Ignite International Brands dividends.
If you bought CA$2,000 of Ignite International Brands shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Ignite International Brands's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Ignite International Brands's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:BILZ Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Ignite International Brands has not reported any payouts.
  • Unable to verify if Ignite International Brands's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Ignite International Brands's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Ignite International Brands has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Ignite International Brands's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Ignite International Brands afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Ignite International Brands has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

BILZ Management

 What is the CEO of Ignite International Brands's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Dan Bilzerian
AGE 38
TENURE AS CEO 0.7 years
CEO Bio

Mr. Dan Bilzerian serves as Chairman at Ignite International Brands, Ltd (also known as ALQ Gold Corporation) since January 9, 2019 and serves as its Chief Executive Officer and Director since January 8, 2019. Mr. Bilzerian became one of the world's most successful professional poker players. As Chairman and Founder of the Ignite Group of Companies, he has launched a trusted and premium global cannabis brand. After serving four years and being honorably discharged from the United States Navy, Mr. Bilzerian attended the University of Florida where he majored in Business and Criminology.

CEO Compensation
  • Insufficient data for Dan to compare compensation growth.
  • Insufficient data for Dan to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team

Dan Bilzerian

TITLE
Chairman & CEO
AGE
38
TENURE
0.7 yrs

Jim McCormick

TITLE
President
AGE
52

Eddie Mattei

TITLE
CFO & Corporate Secretary
AGE
48

Oliver Holzmann

TITLE
Global Head of Marketing
TENURE
0.2 yrs
Board of Directors Tenure

Average tenure and age of the Ignite International Brands board of directors in years:

0.7
Average Tenure
55
Average Age
  • The average tenure for the Ignite International Brands board of directors is less than 3 years, this suggests a new board.
Board of Directors

Dan Bilzerian

TITLE
Chairman & CEO
AGE
38
TENURE
0.7 yrs

Lu Galasso

TITLE
Director
AGE
63
TENURE
0.7 yrs

Scott Rohleder

TITLE
Director
AGE
55
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
03. Jun 19 Buy 1260356 Ontario Limited Company 30. May 19 30. May 19 1,060,000 CA$1.72 CA$1,823,200
31. May 19 Buy Cordell Consultants, Inc. Company 30. May 19 30. May 19 16,666,667 CA$1.50 CA$24,999,991
31. May 19 Buy Atlas Investments, Ltd. Company 30. May 19 30. May 19 35,775,000 CA$1.72 CA$61,533,016
31. May 19 Buy Vulcan Enterprises SKN, Ltd. Company 30. May 19 30. May 19 25,440,000 CA$1.72 CA$43,756,812
31. May 19 Buy Good Spirits Hospitality Limited Company 30. May 19 30. May 19 5,406,000 CA$1.72 CA$9,298,322
X
Management checks
We assess Ignite International Brands's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Ignite International Brands has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

BILZ News

Simply Wall St News

BILZ Company Info

Description

Ignite International Brands, Ltd. operates in cannabis industry in the United States and Canada. It offers joints, drops, and vape products under the IGNITE brand name. The company is based in Toronto, Canada.

Details
Name: Ignite International Brands, Ltd.
BILZ
Exchange: CNSX
Founded:
CA$385,274,236
256,849,491
Website: http://www.igniteinternational.co
Address: Ignite International Brands, Ltd.
11 Cidermill Avenue,
Unit 200,
Toronto,
Ontario, L4K 4B6,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX BILZ Subordinate Voting Shares Canadian National Stock Exchange CA CAD 03. Jun 2019
OTCPK BILZ.F Subordinate Voting Shares Pink Sheets LLC US USD 03. Jun 2019
Number of employees
Current staff
Staff numbers
0
Ignite International Brands employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/20 01:38
End of day share price update: 2019/09/19 00:00
Last earnings filing: 2019/08/29
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.